0 likes | 0 Views
This global Head and Neck Cancer Therapeutics report analyzes the market based on Drug Class, Treatment Type, Route of Administration, End-User, and by geographic region for 2021-2030 period in terms of value in US$ million, projected from 2024 through 2030. The global market for Head and Neck Cancer Therapeutics is estimated at US$1.7 billion in 2024 and is anticipated to post a CAGR of 9.4% during the 2024-2030 analysis period and stand at a projected US$3 billion by 2030.
E N D